News & Events

Announcements

Category:Research

With the prevalence of the highly transmissible delta variant and the corresponding new wave of COVID-19 cases, there is growing interest in the potential use of booster doses for vaccinated populations. 

in Research
New Evidence Points To Antibodies As A Reliable Indicator Of Vaccine Protection
NPR,
,div class="body">

Fred Hutch biostatisticians and UW faculty members Holly Janes and Peter Gilbert spoke with NPR about new evidence that points to antibodies as a reliable indicator of vaccine protection. David Benkeser (PhD, '15) is also quoted.

in Research
Pre-print: Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: experiences from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program
ArXiv.org,
,div class="body">

Commentary and concrete recommendations on the use and reporting of race, ethnicity, and ancestry across the arc of genetic research, including terminology, data harmonization, analysis, and reporting.

in Research
Scientists Have Discovered a Hotspot of Denisovan Ancestors
Gizmodo,
,div class="body">

Sharon Browning is quoted about new research published in Current Biology that shows the Ayta Magbukun have retained around 5% of their Denisovan ancestry.

in Research
A Woolly Mammoth's Tusks Reveal a Map of Where it Roamed in Life
The New York Times,
,div class="body">

New study co-authored by Biostatistics faculty member Amy Willis is featured, explaining how an international team of scientists used a statistical model to reconstruct the lifetime travel patterns of a woolly mammoth.

in Research
Analysis of a 17,000-year-old fossil has revealed remarkable details about the travel patterns of an Arctic woolly mammoth who, throughout its 28-year life, walked the equivalent of nearly two trips around the world.
in Research
Researchers pinpoint 'correlates of protection' for Moderna vaccine
Fred Hutchinson Cancer Research Center Hutch News,
,div class="body">

In the race to develop new and better vaccines and boosters to block COVID-19, scientists are eagerly seeking laboratory tests that can measure immune responses to quickly show how well these shots are working, instead of waiting months for results of clinical trials involving tens of thousands of people.

Now, a group of top scientists, including Dr. Peter Gilbert, a biostatistician at Seattle’s Fred Hutchinson Cancer Research Center, are reporting that they have defined such measurements — or correlates of protection — for the widely used Moderna mRNA vaccine.

in Research
Study showing antibody levels protecting against COVID-19 could speed creation of new vaccines, boosters
USA Today,
,div class="body">

Eagerly anticipated new research pinpoints antibodies scientists can test for to see if a COVID-19 vaccine is effective. These "correlates of protection" could speed the development of new vaccines or boosters without requiring the enormous clinical trials used to create the first COVID-19 vaccines. This is "the Holy Grail" in terms of vaccines, and one that hasn't yet been set for the virus that causes COVID-19, said Peter Gilbert, co-author of the study posted August 10 to medRxiv and a UW research professor of biostatistics.

in Research